Literature DB >> 27271258

[The WHO/ISUP grading system for renal carcinoma].

H Moch1.   

Abstract

Histological tumor grading is an accepted prognostic parameter of renal cell carcinoma (RCC). In 2012, the International Society of Urologic Pathologists (ISUP) proposed a novel grading system for RCC, mainly based on the evaluation of nucleoli: grade 1 tumors have nucleoli that are inconspicuous and basophilic at ×400 magnification; grade 2 tumors have nucleoli that are clearly visible at ×400 magnification and eosinophilic; grade 3 tumors have clearly visible nucleoli at ×100 magnification; and grade 4 tumors have extreme pleomorphism or rhabdoid and/or sarcomatoid morphology. This grading system was validated for clear cell renal cell carcinoma and papillary renal cell carcinoma. At the same time, the ISUP proposed not grading chromophobe renal cell carcinomas according to this system. At a consensus conference in Zurich the World Health Organization (WHO) recommended the ISUP grading system; thus, the WHO/ISUP grading system is now going to be implemented internationally. The ISUP/WHO grading system has not been validated as a prognostic parameter for other tumor subtypes, but can be used for descriptive purposes.

Entities:  

Keywords:  Fuhrman; Grading; International Society of Urological Pathology; Renal cancer; WHO

Mesh:

Year:  2016        PMID: 27271258     DOI: 10.1007/s00292-016-0171-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  45 in total

1.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Parenchymal carcinoma of the kidney.

Authors:  I H GRIFFITHS; A C THACKRAY
Journal:  Br J Urol       Date:  1949-06

3.  Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.

Authors:  M de Peralta-Venturina; H Moch; M Amin; P Tamboli; S Hailemariam; M Mihatsch; J Javidan; H Stricker; J Y Ro; M B Amin
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

4.  Histological grading of renal cell carcinoma.

Authors:  P Hermanek; A Sigel; S Chlepas
Journal:  Eur Urol       Date:  1976       Impact factor: 20.096

5.  Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation.

Authors:  F Jiang; H Moch; J Richter; C Egenter; T Gasser; L Bubendorf; R Gschwind; G Sauter; M J Mihatsch
Journal:  J Pathol       Date:  1998-08       Impact factor: 7.996

6.  Stratification of risk factors in renal cell carcinoma.

Authors:  C Selli; W M Hinshaw; B H Woodard; D F Paulson
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

7.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

8.  Prognosis of renal cell carcinoma related to nuclear grade, DNA content and Robson stage.

Authors:  G Klöppel; W T Knöfel; H Baisch; U Otto
Journal:  Eur Urol       Date:  1986       Impact factor: 20.096

9.  Renal cell carcinoma. II. Histological indicators of prognosis.

Authors:  B Delahunt; J N Nacey
Journal:  Pathology       Date:  1987-07       Impact factor: 5.306

Review 10.  Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.

Authors:  Christian Eichelberg; Kerstin Junker; Börje Ljungberg; Holger Moch
Journal:  Eur Urol       Date:  2009-01-13       Impact factor: 20.096

View more
  18 in total

1.  2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma.

Authors:  Yanyan Zhao; Caixia Wu; Wei Li; Xueqi Chen; Ziao Li; Xuhe Liao; Yonggang Cui; Guangyu Zhao; Meng Liu; Zhanli Fu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-19       Impact factor: 9.236

2.  Usefulness of computed tomography textural analysis in renal cell carcinoma nuclear grading.

Authors:  Israa Alnazer; Omar Falou; Pascal Bourdon; Thierry Urruty; Rémy Guillevin; Mohamad Khalil; Ahmad Shahin; Christine Fernandez-Maloigne
Journal:  J Med Imaging (Bellingham)       Date:  2022-09-13

Review 3.  Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Authors:  Francesco Trevisani; Matteo Floris; Riccardo Vago; Roberto Minnei; Alessandra Cinque
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

4.  The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.

Authors:  Sung Han Kim; Weon Seo Park; Eun Young Park; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Kang Hyun Lee; Jinsoo Chung
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

5.  High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma.

Authors:  Ning Na; Heng Li; Chengfang Xu; Bin Miao; Liangqing Hong; Zhengyu Huang; Qiu Jiang
Journal:  Ther Clin Risk Manag       Date:  2017-02-27       Impact factor: 2.423

6.  Analysis of the concordance of 20 immunohistochemical tissue markers in metastasectomy lesions in patients with metastatic renal cell carcinoma: A retrospective study using tissue microarray.

Authors:  Sung Han Kim; Weon Seo Park; Eun Young Park; Jungnam Joo; Jinsoo Chung
Journal:  Investig Clin Urol       Date:  2020-05-25

7.  CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.

Authors:  Jian Liu; Zhe Liu; Qun Liu; Lina Li; Xiaona Fan; Tao Wen; Guangyu An
Journal:  Oncol Rep       Date:  2018-07-23       Impact factor: 3.906

Review 8.  Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Lijin Zhang; Zhenlei Zha; Wei Qu; Hu Zhao; Jun Yuan; Yejun Feng; Bin Wu
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

9.  MicroRNAs as Urinary Biomarker for Oncocytoma.

Authors:  Melanie von Brandenstein; Monika Schlosser; Jan Herden; Axel Heidenreich; Stefan Störkel; Jochen W U Fries
Journal:  Dis Markers       Date:  2018-07-16       Impact factor: 3.464

10.  New Preoperative Nomogram Using the Centrality Index to Predict High Nuclear Grade Clear Cell Renal Carcinoma.

Authors:  Zhan Feng; Shuangshuang Lou; Lixia Zhang; Liang Zhang; Wenting Lan; Minhong Wang; Qijun Shen; Zhengyu Hu; Feng Chen
Journal:  Cancer Manag Res       Date:  2019-12-31       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.